Ozempic maker Novo Nordisk on Wednesday said data ... after 12 weeks and patients taking one amycretin pill a day had weight ...
Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight off competition from rivals in a highly competitive market. The company announced the completion of two ...